Bio-Oxidative solutions Inc.



What this graph is showing, that there has been no decay of EMODs in this solution. This shows 10 hours of stable EMOD concetraton at room temperature. This also means the substrate of the solution, does not react with 0^-1 species. This graph also shows, alost zero reaction with highly electronegtive free radical species. It is essentially equivalent to a vacuum environment.

This also means, the way we can deliver compunds like Polyphyrins now has changed as well. Polyphyrins are photo dynamically activated drugs that can be now be activated outside the patient, then can be injected as needed with precision, and without the need of a surgical procedure.  This means we can now deliver the drug to any specific region of interest as necessary, without messy complications, and this can be done with a dose dependent precision that cannot be matched otherwise.  Before this discovery, we had to deliver the photo activated drugs intravenously, and then perform an operation, to expose the tumor to photon energy for radical activation. There are many unknowns with this procedure, such that, how many radicals are actually activated.  Also, we are only attacking the outer membrane of the tumor. With this direct injection and activation method, we could we can get deep down inside of the maligned cell, to oxidize all its organelles. And this is truly a localized effect.







 This graph shows the Control in H20.  The electronically modified oxygen derivatives reach half life in 8 min's, and completely decayed in 16 min. This is what plagued free radical therapy, including Photo-dynamic therapy from it's inception.

 This is a true stabilization technology, due to a non reactive bio compatible solution. The dose can now be stabilized and then directly injected as needed.  We achieved a 2.8 % concentration per volume in C6F14 perfleuerohexane.

 We can deliver 1cc dose injections. This can also help the sports medicine industry as well, in the area of damage knee cartilages, herniated disc repair and for tendon injuries.

The sports medicine market alone is worth 4 billion annually.

Currently the Photo dynamic cancer therapy market has 1% market share. This is due to the completed nature of delivery of EMODs. We have changed that.

 Tools used in the experment Pdf.